Camber Capital Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-22,000
| Closed | -$8.27M | – | 38 |
|
|
2020
Q4 | $8.27M | Sell |
22,000
-3,000
| -12% | -$1.13M | 0.29% | 28 |
|
|
2020
Q3 | $7.68M | Sell |
25,000
-5,000
| -17% | -$1.54M | 0.4% | 31 |
|
|
2020
Q2 | $11.3M | Sell |
30,000
-5,000
| -14% | -$1.88M | 0.65% | 27 |
|
|
2020
Q1 | $7.98M | Hold |
35,000
| – | – | 0.48% | 26 |
|
|
2019
Q4 | $18.5M | Hold |
35,000
| – | – | 0.94% | 25 |
|
|
2019
Q3 | $15.1M | Buy |
+35,000
| New | +$15.1M | 0.79% | 28 |
|